PACS - PACS Group, Inc.

PACS - PACS Group, Inc.

https://pacs.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PACS Group, Inc. - PACS - PACS Group ( NYSE:PACS )

Benzinga • 1 day, 1 hour ago • score: -0.11

NEW YORK, Sept. 14, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ( "PACS" or the "Company" ) PACS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

PACS Group, Inc. ( PACS ) Soars 24.5%: Is Further Upside Left in the Stock?

Zacks Commentary • 3 days, 6 hours ago • score: 0.33

PACS Group, Inc. (PACS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday - Bitfarms ( NASDAQ:BITF ) , Centene ( NYSE:CNC )

Benzinga • 4 days ago • score: 0.42

U.S. stocks were higher, with the Nasdaq Composite gaining more than 100 points on Thursday. Shares of Maze Therapeutics, Inc. MAZE rose sharply during Thursday's session after the company reported clinical results from its Phase 1 healthy volunteer study of MZE782.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

None

52W High

$43.92

52W Low

$8.28

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

Attractive

As of 2024-06-30 (Overview)

Trailing P/E (<15 better)

18.31

Forward P/E (<15 better)

4.99

EV/EBITDA (<8 favorable)

20.04

EV/Revenue (<3 favorable)

1.22

P/S (TTM) (<3 favorable)

0.49

P/B (<3 favorable)

3.03

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

72.29%

Institutions (25–75% balanced)

29.08%

Shares Outstanding

155,178,000

Float

43,040,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

As of 2024-06-30 (Overview)

Revenue (TTM)

3,558,953,000

Gross Profit (TTM)

519,142,000

EPS (TTM)

0.61

Profit Margin (>10% good)

0.03%

Operating Margin (TTM) (higher better)

0.00%

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.29

Momentum

Bearish momentum

Value

-0.1032

Previous

-0.0755

Trend

Falling

Signal Cross

No cross

As of

Sep. 05, 2025